Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRubio Pérez, Carlota
dc.contributor.authorPlanas Rigol, Ester
dc.contributor.authorTrincado, Juan L.
dc.contributor.authorBonfill Teixidor, Ester
dc.contributor.authorArias Piñeiro, Alexandra
dc.contributor.authorMarchese, Domenica
dc.contributor.authorIurlaro, Raffaella
dc.contributor.authorMartínez Ricarte, Francisco Ramón
dc.contributor.authorEscudero Monreal, Laura
dc.contributor.authorCordero Asanza, Esteban Xavier
dc.contributor.authorCicuendez López Ocaña, Marta
dc.contributor.authorNuciforo, Paolo Giovanni
dc.contributor.authorSahuquillo Barris, Joan
dc.contributor.authorTabernero Caturla, Josep
dc.contributor.authorSeoane Suarez, Joan
dc.contributor.authorSerna, Garazi
dc.date.accessioned2021-07-15T12:22:26Z
dc.date.available2021-07-15T12:22:26Z
dc.date.issued2021-03-08
dc.identifier.citationRubio-Perez C, Planas-Rigol E, Trincado JL, Bonfill-Teixidor E, Arias A, Marchese D, et al. Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment. Nat Commun. 2021 Mar 8;12(1):1503.
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/11351/6171
dc.descriptionMicroambient del càncer; Immunologia tumoral
dc.description.sponsorshipThe study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), FERO (EDM), Ramón Areces Foundation, Cellex Foundation, BBVA (CAIMI), the ISCIII, FIS (PI16/01278), the Ministerio de Ciencia, Innovación y Universidades (SAF2017-89109-P; AEI/FEDER, UE), the Juan de la Cierva formación fellowship (C.R.-P. and L.E.), Sara Borrell fellowship (E.P-R.). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, and the Co-financing by the Spanish Ministry of Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program.
dc.language.isoeng
dc.publisherNature Research
dc.relation.ispartofseriesNature Communications;12(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCervell - Tumors
dc.subjectCàncer - Immunoteràpia
dc.subjectMetàstasi
dc.subject.meshBrain Neoplasms
dc.subject.meshAntineoplastic Agents, Immunological
dc.subject.meshNeoplasm Metastasis
dc.titleImmune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41467-021-21789-x
dc.subject.decsneoplasias cerebrales
dc.subject.decsinmunoterapia antineoplásica
dc.subject.decsmetástasis neoplásica
dc.relation.publishversionhttps://www.nature.com/articles/s41467-021-21789-x
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Rubio-Perez C, Planas-Rigol E, Bonfill-Teixidor E, Arias A, Serna G, Iurlaro R, Escudero L, Nuciforo P] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Trincado JL] CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Josep Carreras Leukemia Research Institute and Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. [Marchese D] CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. [Martínez-Ricarte F, Cordero E, Cicuendez M, Sahuquillo J] Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Tabernero J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERONC, Barcelona, Spain. [Seoane J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. CIBERONC, Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
dc.identifier.pmid33686071
dc.identifier.wos000627442600001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01278
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/SAF2017-89109-P
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple